Octreotide in the United States

13 medicine records from 8 holders carry this name in the official sources. Collected on November 19, 2026.

Medicines

Holders and status of these records
Name Holder Code
Mycapssa CAPSULE, DELAYED RELEASE Chiesi USA, Inc. Product NDC 10122-550Package NDC 10122-550-28
Mycapssa CAPSULE, DELAYED RELEASE Amryt Pharmaceuticals Designated Activity Company Product NDC 69880-120Package NDC 69880-120-28
Octreotide POWDER BCN PEPTIDES SA Product NDC 35207-0002Package NDC 35207-0002-5
Octreotide POWDER Ambiopharm, Inc. Product NDC 41524-0007Package NDC 41524-0007-1
Octreotide POWDER Bachem Americas, Inc. Product NDC 52416-109Package NDC 52416-109-01
Octreotide POWDER USV Private Limited Product NDC 62147-0206Package NDC 62147-0206-0
Octreotide INJECTION, SOLUTION Fresenius Kabi USA, LLC Product NDC 63323-376Package NDC 63323-376-01
Octreotide INJECTION, SOLUTION Fresenius Kabi USA, LLC Product NDC 63323-376Package NDC 63323-376-04
Octreotide INJECTION, SOLUTION Fresenius Kabi USA, LLC Product NDC 63323-377Package NDC 63323-377-01
Octreotide INJECTION, SOLUTION Fresenius Kabi USA, LLC Product NDC 63323-377Package NDC 63323-377-04
Octreotide INJECTION, SOLUTION Fresenius Kabi USA, LLC Product NDC 63323-378Package NDC 63323-378-05
Octreotide INJECTION, SOLUTION Fresenius Kabi USA, LLC Product NDC 63323-379Package NDC 63323-379-05
Octreotide POWDER LSNE, Inc. Product NDC 73301-004Package NDC 73301-004-01

Need this list in your own system?

Every record on this page is available through the API, with its source, licence and retrieval date.